Skip to main content
UCB logo

UCB — Investor Relations & Filings

Ticker · UCB ISIN · BE0003739530 LEI · 2138008J191VLSGY5A09 BR Manufacturing
Filings indexed 2,018 across all filing types
Latest filing 2022-05-12 AGM Information
Country BE Belgium
Listing BR UCB

UCB is a global biopharmaceutical company that focuses on creating solutions for people living with severe diseases, primarily in the fields of neurology and immunology. The company's core activities include the research, development, and commercialization of pharmaceutical and biotechnology products. Guided by a patient-centric and science-driven approach, UCB is committed to innovation and sustainability. Through its UCB Ventures arm, it invests in pioneering technologies and companies with the potential to transform patient care. The company also offers personalized support services to patients and healthcare professionals during their treatment journey with a UCB medicine.

Recent filings

Filing Released Lang Actions
Minutes EGM 28.04.22 - ENG.pdf
AGM Information Classification · 1% confidence The document text explicitly details the proceedings of an 'extraordinary general meeting of the shareholders' of UCB, held on April 28th, 2022. The agenda items include 'AMENDMENT OF THE ARTICLES OF ASSOCIATION', 'RENEWAL OF THE AUTHORIZED CAPITAL', and 'AUTHORIZATION TO ACQUIRE OWN SHARES'. The document records the resolutions passed by the shareholders regarding these corporate governance and capital structure matters. This content is characteristic of the minutes or official record of an Annual General Meeting (AGM) or Extraordinary General Meeting (EGM). Since the classification options include 'AGM-R' (AGM Information) and the document is the formal record of decisions made during such a meeting, AGM-R is the most appropriate classification, as it covers the official proceedings and resolutions of a general meeting.
2022-05-12 English
PV EGM 28.04.22 - FR.pdf
AGM Information Classification · 1% confidence The document is a formal legal record detailing decisions made during an 'assemblée générale extraordinaire des actionnaires' (Extraordinary General Meeting of Shareholders) of UCB SA, dated April 28, 2022. The content explicitly covers resolutions regarding the renewal of the authorized capital structure (Article 6 modification) and the authorization to acquire own shares (Article 7:215 CBSA), which are typical items discussed and voted upon at a shareholder meeting. The structure, including the 'Bureau', 'Ordre du jour', 'Quorum', and 'Délibération et Résolutions', strongly indicates this is the official minutes or a summary of the proceedings of a General Meeting. Since it details the voting results and decisions made during the meeting, it aligns best with the context of an Annual General Meeting (AGM) or Extraordinary General Meeting documentation, even though it is not explicitly labeled 'AGM-R' (which usually implies presentation materials). Given the focus on statutory changes and capital authorization renewal, it is a core document related to shareholder governance, making AGM-R the most appropriate fit among the provided codes, as it documents the formal actions taken at such a meeting.
2022-05-12 French
Notulen EGM 28.04.22 - NL.pdf
AGM Information Classification · 1% confidence The document text is a notarial deed detailing the proceedings of an 'buitengewone algemene vergadering der aandeelhouders' (Extraordinary General Meeting of Shareholders) of UCB NV, held on April 28, 2022. The agenda items explicitly discuss the renewal of the authorized capital mandate for share buybacks and amendments to the articles of association (statutenwijzigingen). This content—minutes and resolutions from a shareholder meeting—is characteristic of an Annual General Meeting (AGM) or Extraordinary General Meeting (EGM) record. Since the document records the meeting itself, including the agenda, quorum, and resolutions, the most appropriate classification is AGM-R (AGM Information), which covers presentations and materials shared during the AGM.
2022-05-12 Dutch
PR 22 avril 2022 - ENG.pdf
Director's Dealing Classification · 1% confidence The document is titled "Disposal of own shares" and details transactions where UCB disposed of its own shares OTC following the exercise of stock options by personnel under various Long-Term Incentive (LTI) Plans. This activity directly corresponds to the definition of a company buying back or selling its own shares. The filing type code matching this description is 'POS' (Transaction in Own Shares). The document is a formal announcement (Regulated information) and not merely an announcement of a report, thus RPA/RNS is not the primary classification.
2022-04-22 English
PR 22 avril 2022 - FR.pdf
Transaction in Own Shares Classification · 1% confidence The document title is "Aliénation d'actions propres" (Alienation of own shares) and it details transactions where UCB SA disposed of its own shares following the exercise of options by employees as part of long-term variable remuneration. This directly corresponds to the definition of a company buying back or selling its own shares (share repurchase/issuance). The applicable code is POS (Transaction in Own Shares). The document is short and appears to be a formal regulatory disclosure, not an announcement of a larger report.
2022-04-22 French
PR 22 avril 2022 - NL.pdf
Transaction in Own Shares Classification · 1% confidence The document title is "Vervreemding van eigen aandelen" (Disposal of own shares) and the content details transactions where UCB shares were disposed of (delivered) to employees under long-term incentive plans (Stock Option Plans) on specific dates. This directly relates to the company buying back or issuing its own shares, specifically in the context of employee stock options being exercised and shares being delivered. This aligns perfectly with the definition for 'Transaction in Own Shares' (POS). The document is short and appears to be a regulatory disclosure of these specific transactions.
2022-04-22 Dutch

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.